Close association between HER-2 amplification and overexpression in human tumors of non-breast origin (Q79954721)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Close association between HER-2 amplification and overexpression in human tumors of non-breast origin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Coya Tapia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Katharina Glatz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hedvika Novotny

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Alessandro Lugli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Milo Horcic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Christian A Seemayer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Luigi Terracciano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hanspeter Spichtin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Martina Mirlacher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Guido Sauter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

192-198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361205%20AND%20SRC:MED&resulttype=core&format=json

ERBB receptors and cancer: the complexity of targeted inhibitors

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

The ErbB receptors and their ligands in cancer: an overview.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Antitumor activity of HER-2 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Trastuzumab: hopes and realities

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Trastuzumab trials steal show at ASCO meeting

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Prognostic factors and c-erbB-2 expression in non-small-cell lung carcinoma (c-erbB-2 in non-small cell lung carcinoma).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Tissue microarrays in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Overexpression of her-2/neu in human prostate cancer and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Assessment of HER‐2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

The HER-2/neu oncogene in tumors of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Her-2/neu oncogene amplification in clinically localised prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800729

7 January 2021